MRI-guided radiation therapy for anal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new, more precise type of radiation therapy for anal cancer. It uses daily MRI scans to adjust the radiation dose based on how the tumor shrinks, aiming to give stronger treatment to the cancer while protecting healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have squamous cell carcinoma (a type of skin-like cancer) of the anus or anal margin.
- Your cancer is at a stage that hasn't spread to distant organs (T1-4, N0-1, M0).
- You are healthy enough for radiation therapy or chemoradiation — your doctor says it's an option for you.
- You are 18 years or older.
- Your daily activity level is fairly good (ECOG score of 0, 1, or 2).
- You have not had chemotherapy, radiation, or major surgery for anal cancer before, and haven't had radiation to your belly or pelvis that would overlap.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an adaptive, image-guided radiation plan for anal canal squamous-type cancers. It may help deliver effective treatment while adjusting the radiation based on how your body and tumor respond.
This trial tests an online, adaptive way to plan and adjust radiation during treatment for people with biopsy-proven anal cancer. The goal is to better target the cancer while keeping side effects as low as possible.
This trial tests a new way of giving radiation therapy for rectal cancer, using MRI scans to aim the radiation more precisely. It's for people who need chemotherapy and radiation before surgery, and it aims to make treatment more effective while reducing side effects.
This trial tests whether using MRI scans to guide radiotherapy can improve treatment for people with a certain type of rectal cancer. It focuses on patients whose tumors have not spread to other parts of the body and who have specific tumor features seen on MRI.
This trial tests whether radiation therapy can be adjusted each session using MRI images to better target rectal cancer while sparing healthy tissue. It's for patients with stage II or III rectal cancer that hasn't spread to other parts of the body.
This study compares standard radiation (IMRT) with a newer, more precise type (IMPT) both given alongside chemotherapy for anal cancer. It aims to see which is better at controlling cancer and reducing side effects.
Hear when a new Anal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.